Search

Your search keyword '"Bjerke M"' showing total 179 results

Search Constraints

Start Over You searched for: Author "Bjerke M" Remove constraint Author: "Bjerke M"
179 results on '"Bjerke M"'

Search Results

1. Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores (Nature Communications, (2021), 12, 1, (3417), 10.1038/s41467-021-22491-8)

2. Patients carrying the mutation p.R406W in MAPT present with non-conforming phenotypic spectrum

3. New insights into the genetic etiology of Alzheimer's disease and related dementias

4. Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overview

5. Investigating Tissue-Specific Abnormalities in Alzheimer's Disease with Multi-Shell Diffusion MRI

6. Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

7. Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

8. Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overview

9. Hippocampal Sclerosis in Frontotemporal Dementia: When Vascular Pathology Meets Neurodegeneration

10. Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker-based case-control study

12. Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis

13. Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry

14. Biochemical markers in vascular cognitive impairment associated with subcortical small vessel disease - A consensus report

15. Biochemical markers in vascular cognitive impairment associated with subcortical small vessel disease : a consensus report

16. Biochemical markers in vascular cognitive impairment associated with subcortical small vessel disease - A consensus report

17. CSF biomarkers to predict rate of cognitive decline in Alzheimer’s disease

18. Discordance between amyloid-PET and CSF amyloid-β for diagnosing Alzheimer’s disease in a clinical setting

22. Reference measurement procedures for Alzheimer's disease cerebrospinal fluid biomarkers: definitions and approaches with focus on amyloid beta42.

36. Amyloid-β₄₂ is associated with cognitive impairment in healthy elderly and subjective cognitive impairment.

37. Reduced Levels of Mitochondrial DNA Increases the Toxicity of 9-ss-D-Arabinofuranosylguanine (araG).

38. Investigation of the Substrate Recognition of Drosophila melanogaster Nucleoside Kinase by Site Directed Mutagenesis.

44. Effects of dietary supplementation of coriander oil, in canola oil diets, on the metabolism of [1-14C] 18:3n-3 and [1-14C] 18:2n-6 in rainbow trout hepatocytes.

48. Brain age as a biomarker for pathological versus healthy ageing - a REMEMBER study.

49. Towards validation in clinical routine: a comparative analysis of visual MTA ratings versus the automated ratio between inferior lateral ventricle and hippocampal volumes in Alzheimer's disease diagnosis.

50. A metformin add-on clinical study in multiple sclerosis to evaluate brain remyelination and neurodegeneration (MACSiMiSE-BRAIN): study protocol for a multi-center randomized placebo controlled clinical trial.

Catalog

Books, media, physical & digital resources